This survey seeks the opinion of UK community pharmacists to identify barriers in the public health role of community pharmacists.
Introduction
A number of UK studies have confirmed the role of pharmacists in public health. [1] [2] [3] [4] [5] [6] However, a number of studies have also identified barriers hindering the public health role of community pharmacists. These include: time pressure and workload; 4,7-10 the training of pharmacists and their staff; 4, 10, 11, 12 and inadequate remuneration and lack of support from stakeholders. 4, 9, 10, 11, 13 At the same time, safety concerns 10, 14 and lack of documentation 10, 15, 16 have also been recognised as barriers hindering the provision of public health services from community pharmacies.
However, as many of the identified barriers have originated from studies that were conducted overseas, some of their findings may not be generalisable to the UK. This survey seeks the opinion of UK community pharmacists to identify barriers hindering the public health role of community pharmacists in the UK.
Methods
This study was approved by the programme approval panel (PAP) and research ethics subcommittee (RESC) of the University and took the form of a descriptive, cross-sectional survey that generated mostly quantitative data. Items were selected and included in the questionnaire based on the identified themes in the review of literature and information, 10 with assistance from J.O. and J.P. (content or face validity). 17 The questionnaire was designed to take approximately 20 minutes to complete, with assurance of the confidentiality of the responses. The questionnaire was pilot tested for content, clarity and format of the questions on a group of 150 randomly selected community pharmacists in Bedfordshire area, England, as listed on the NHS Choices website. 18 The purpose of the study was explained, with the response rate for the pilot study being 39% (59/150), after two reminders (three weeks apart). The Cronbach's alpha was also calculated to estimate the internal consistency of the pilot survey questionnaire. Based on the 56 items tested on the pilot questionnaire, the SPSS reliability test indicated that the Cronbach's alpha was 0.787. As this number (0.787) was greater than 0.7, there was no need to alter the questionnaire. 19 The questionnaire was designed to collect the demographic characteristics of the respondents, such as gender, age, and years of post-qualification experience. 20 The respondents were also requested to give their opinions on the perceived barriers to enhancing the public health role of community pharmacists in the UK, using a scale of 1-5 (1 = disagree, 2 = strongly disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree). 20 J.O. and J.P. approved the questionnaire before its use. For the main study, the questionnaires were mailed with covering letters to 385 randomly selected community pharmacists from Barnet, London, and its surrounding areas, Cardiff and Edinburgh. The covering letter introduced the researchers, summarised the purpose of the study and guaranteed confidentiality. Two reminders were sent at three-week intervals to nonresponders to enhance the response rate. All statistical analyses were performed using the most recent version of the Statistical Package for the Social Sciences (SPSS 19.0).
Results
Eighty-eight usable responses were collected in the main survey, representing a response rate of 22.8% [88/385]. However, when these were combined with the returned pilot questionnaires (59) [59/150], the combined response rate for all questionnaires received became 28.05% (147/524).
Pharmacists' characteristics
Both men (73 [50%]), and women (73) responded to the survey, C.I. ±8.09. Their age-range distribution is shown in Figure 1 , which indicates that the youngest, as well as highest number of respondents, were aged between 20-29 years (26.5%, C.I. ±7.12), while the oldest, as well as the fewest number of respondents, were aged between 70-79 years (2.0%, C.I. ±2.26). The role distribution of the respondents (Figure 2 ) indicated that a majority of the respondents were working as employee community pharmacists (76.9%, C.I. ±6.8).
Survey responses
Barriers to the public health role of the community pharmacist
In terms of the barriers to enhancing the public health role of community pharmacists in the UK [see Table 1 ], the majority of the respondents identified insufficient training of pharmacists in public health (66.5%, C.I. ±7.64); the lack of professional autonomy for pharmacists (66.9%, C.I. ±7.64); the lack of input from public health practitioners (68.9%, C.I. ±7.52); the lack of support from public health practitioners (69.3%, C.I. ±7.54); and difficulty in communicating with other public health providers (69.5%, C.I. ±7.5) as barriers.
As well as the aforesaid, the majority of respondents also identified the lack of support from GPs (68.2%, C.I. ±7.56); insufficient funding from the government (75.2%, C.I. ±7.01); time pressure and workload (89.7%, C.I. ±4.94); the lack of patients' records (78.6%, C.I. ±6.66); the lack of instrumentation (55.9%, C.I. ±8.06); the lack of understanding by the public of the training and skill sets of pharmacists (72.7%, C.I. ±7.29); and the lack of understanding by healthcare providers of the training and skill sets of pharmacists (73.7%, C.I. ±7.25) as barriers. Conversely, the majority of respondents did not accept that language barriers (53.5%, C.I. ±8.13) and safety concerns of patients (51.1%, C.I. ±8.12) were barriers to enhancing the public health role of community pharmacists.
In addition to the quantitative responses, the questionnaire also provided an option for the respondents to supply, in a free text format, comments about what they considered as barriers to enhancing the public health role of community pharmacists. The barriers that were highlighted varied and included issues such as funding challenges, time pressure, commercial pressure from employers, etc:
Various "Lack of co-ordinated approach by utilising all parties; lack of understanding and acceptance of health promotion before treatment; as well as ring-fenced funding arrangements" [E390].
Commercial Pressure
"Undue pressure to meet targets by pharmacists' employers, due to their selfish financial gain" [P9].
Follow up
"Follow up is difficult to find out why a patient hasn't continued, e.g. NRT. Time constraints to phone each individual patient who hasn't returned" [E454].
Conflict of interest
"GP and GP practices don't want pharmacies in their team -conflict of interest" [B37] .
"GPs think we are taking money from them by providing a service" [RC185] .
Publicity "Government/NHS should emphasise pharmacists' roles more publicly -ever-likely as mandatory for those using NHS services regularly, e.g. mandatory MUR for all on long-term medications" [P133] . According to four respondents, ensuring consistency in service delivery across sectors and/or locations can also help to tackle some of the identified barriers:
"All training should be the same regardless of location, so all extra training can be used anywhere in the country" [P103] . "Firstly, pharmacists themselves need to quantify and specify what they're able to do for the public and patients rather than just taking on what GPs don't want to do anymore for no more money" [E382].
On the other hand, ten of the respondents highlighted the need for collaboration between healthcare professionals, as well as with government bodies. For some, this will also mean GPs delegating certain services to pharmacists, various healthcare professionals seeing pharmacists more as colleagues, rather than as competitors, as well as recognising each others' roles and abilities. Some of these comments are included below:
"Make medical students aware of (the) need to work together for (the) common good of patients at student level" Yet according to another two respondents, the delegation of pharmacists' roles to other health teams might be the way forward:
"Allow dispensers to take the pressure off pharmacists, so they take more responsibility for dispensing scripts and pharmacists can concentrate more on other services" [RE 372].
"Cut down on pharmacy schools and phase out the need for pharmacists and let nurses, doctors and dispensers run local dispensaries" [P12]
In addition, another area of emphasis for many of the respondents was on improving funding for community pharmacy public health activities, which eleven of them identified as a barrier to enhancing the role of pharmacists in public health. However, when the questionnaire asked community pharmacists about how essential it was that patients get public health services from community pharmacies, some 50% of the respondents (C.I. ±8.15) indicated that this was 'very essential'; some 26.4% indicated 'essential' (C.I. ±7.18); 14.6% indicated 'quite essential' (C.I. ±5.76); 8.3% said, 'sometimes' (C.I. ±4.5), while one respondent (0.7%, C.I. ±1.62) disagreed. On the negative aspects of the public health services from community pharmacies and how they could be improved, some of the feedback also included that pharmacists were devalued; problems of commercial pressure from employers; lack of training; funding challenges; lack of privacy and premises arrangement; distractions and lack of commitment from community pharmacists; lack of awareness (fourteen respondents); lack of time (twenty-two respondents); workload and unmanageable stress levels (ten respondents); inconsistency in service delivery; as well as the issue of isolation. Interestingly, some eighty-six percent of the respondents (C.I., ±5.83) also agreed with the statement that 'the public health role of community pharmacists in the UK is still undeveloped in the 21 st century'. For the respondents that said 'yes' to this question, some of the reasons they gave were about the quality of the services provided by community pharmacies, hence, the problem of trust; lack of consistency in service delivery; lack of time to deliver public health services; community pharmacists not feeling professionally empowered enough to provide public health services; lack of training; lack of awareness; difficulty adapting to changing needs; feeling undervalued and unrecognised; and lack of focus. Yet some of the respondents talked about the accessibility of community pharmacy practices.
Quality/trust
"Not enough quality service offered by majority of community pharmacies" [P97]
"Public do not see pharmacy as place to go for public health issues" [PR43] "We are expected to provide a service without specific teaching or training -all we do is learning on our own or through one's own experiences" [E382].
Awareness
"Pharmacists can do a lot more to contribute to public health. Our biggest hurdle is educating the public that we are the first point of call and recognised by NHS" [RB27]. 
Tests for significance and correlation of variables
Tests for significance indicated that the male respondents (median = 5.0) were more likely than the female respondents (median = 4.0) to agree that 'insufficient funding from the government' was a barrier to enhancing the public health role of community pharmacists (p = .006; Eta, η 2 = .053). Regarding a 'language barrier', those aged between 70-79 (median = In terms of location, respondents from Bedfordshire were more likely than respondents from Cardiff, Edinburgh and Barnet (in that order) to agree that 'lack of support from public health practitioners' was a barrier in enhancing the public health role of community pharmacists [ρ = .195; p = .021]. In the same order, respondents from Bedfordshire were more likely to also agree that 'lack of patients' records' was a barrier [ρ = .179; p = .033].
Discussion
This survey has confirmed many of the barriers identified elsewhere. 4, 10 Notably, there is a need to address many of the identified barriers hindering the public health role of community pharmacists in the UK, such as the community pharmacy environment, which sometimes may not be suitable for the delivery of public health services; 21 the negative perceptions by both the general public and other health providers of pharmacists' competencies; privacy and confidentiality in pharmacies; as well as time pressure and a high dispensing workload.
Still, there also seems to be a need to address issues such as the UK healthcare system and its policies towards the public health role of the pharmacist, inadequate training of pharmacists in public health, lack of documentation of activities and inadequate financial support. 4, 10, 16, 22 The need for better funding demands closer attention, particularly when you also consider that the male respondents were, on the average, less happy with the present funding arrangements (p = .006; η 2 = .053) than the female respondents. To encourage younger pharmacists to participate in public health services, direct remuneration to pharmacists might be a game changer (p = .043; η 2 = .078). Yet it seems reasonable that policy makers and other stakeholders should also be aware of the differences that existed in the responses (based on the role of the respondent) that 'insufficient funding from the government' was a barrier to enhancing the public health role of community pharmacists (p = .049; η 2 = .096).
There is also a need to tackle other barriers, which include the lack of professional autonomy for pharmacists, 21 the lack of input from public health practitioners, the lack of support from GPs and public health practitioners, difficulty in communicating with other public health providers, the lack of patients' records, and the lack of understanding by the public and healthcare providers of the training and skill sets of pharmacists. In addition, it seems necessary to minimise commercial pressures from employers, difficulties in following up with patients, the conflict of interest that seems to exist between pharmacists and GPs, as well as the underutilisation of pharmacists' skills. Nevertheless, as suggested by some of the respondents, it is possible to resolve many of the barriers by, for example, getting rid of target-driven services, opening up channels of engagement between pharmacists and stakeholders, reducing professional isolation, ensuring consistency in service delivery across sectors and localities, enhancing collaboration between community pharmacists and other healthcare providers, and ensuring that more than one pharmacist works in community pharmacies at any time, as seen in Italy. In addition, role delegation between pharmacists and other healthcare professionals and pharmacy support staff will also be necessary. Yet there is also a need for pharmacists themselves to be more proactive, assertive and committed to public health activities.
Other challenges faced by community pharmacists in their aspiration to provide public health services relate to the lack of a well-defined career structure and clear progression channels, an unacceptable work-life balance, 23 the unavailability of individually contracted community pharmacists, 24 and the declining ownership of community pharmacies by pharmacists. 22, 25 The conflict of interest which one of our respondents raised as a barrier to enhancing the public health role of community pharmacists in the UK, i.e. "GP and GP practices don't want pharmacies in their team -conflict of interest" [B37], could be managed by encouraging GP practices to employ more pharmacists as recently proposed by the Royal Pharmaceutical Society (RPS) and the Royal College of General Practitioners (RCGP). 26 According to a recent publication, 27 closer ties with general practice -and primary, secondary, tertiary, mental health and social care -are essential to improve the contribution of pharmacists to patient care and to secure better prospects for the profession.
Not surprising, the underutilisation of pharmacists has often been described as a huge waste of resources, as well as a drain on the intellectual skills of pharmacists, 24 particularly in recent times, when other healthcare professionals are struggling to cope with demands which could easily be managed by pharmacists. From some of the comments in this study, it was obvious that UK community pharmacists would like the underutilisation of pharmacists to be reversed. Yet to address some of these challenges, the profession might also need to consider a recent proposal to separate the dispensing role of pharmacists from the pharmacy/public health services role, 28 while at the same time, promoting the establishment of healthy living pharmacies in the UK. 29 Supporting the notion that there is a variation in the relationships between GPs and community pharmacists across the UK is the revelation that respondents from Edinburgh (median = 3.0) were less likely than other respondents to agree that 'lack of support from GPs' was a barrier to enhancing the role of community pharmacists in public health (p < .001; η 2 = .157; Total median = 4.0). This variation might need to be investigated further and then managed. While the majority of survey respondents felt that the lack of patients' records (78.6%, C.I. ±6.66) was a barrier to enhancing the public health role of the community pharmacist, a much lower number of respondents (52.1%, C.I. ±8.14) identified the lack of documentation of public health interventions as a barrier to enhancing this role.
For some time, a UK professional association has advocated that community pharmacists be given access to patients' Summary Care Records. 30, 31 According to the professional association, the availability of 'Summary Care' records will allow the application of highly developed clinical skills that only a pharmacist can perform. 31 The recent announcement that SCR access will soon be rolled out to community pharmacists across England is not only an encouraging development, 32 but will hopefully help to enhance both the clinical, as well as the public health skills of pharmacists. Despite the benefits, it has, however, been noted that access to Summary Care health records is not risk free, particularly as it may not only increase the risk of prosecution, but could also increase the risk of civil claims for any injury caused by a dispensing error in some circumstances. 33 
Recommendation for further studies
This study identified a number of significant differences and correlations between variables, particularly in terms of gender, the role of the respondents and the location of practice.
Further research in these areas might be needed to identify how tackling these differences could help to enhance the public health role of community pharmacists in the UK.
Limitations
The response rate for this study was very low. However, its impact on the generalisability of the results was minimised by the relatively large sample size used in the study and the study's reporting of free text comments, as well as confidence intervals (C.I.), in the results.
A low response rate is, however, not uncommon for health surveys. [34] [35] [36] The main contributing factor to the low response rate might have been the length of the survey questionnaire (which listed sixty-three items, including free text options). Again, the fact that the researchers did not have multiple contacts for the respondents or offer any financial incentives also might have affected the survey response rate negatively. 37 Still, it is possible that the poor response rate recorded in this study could be a reflection of how disengaged UK community pharmacists are with the profession. 38, 39 
Conclusions
There are numerous opportunities for community pharmacists in public health. 10, [40] [41] [42] However, several barriers associated with the public health role of community pharmacists have been identified as hindering the enhancement of this role; one of them is that the UK's community pharmacy public health practice is still operating at a basic level. 1, 2, 4 Although the pharmacy profession is gradually evolving from product-oriented to patient-centred care, with pharmacists now contributing to micro-level public health activities, there continues to be an unmet need for UK pharmacists in macro-level public health functions. 43 To achieve this desired objective, both in the UK and globally, it will be necessary to enhance, among other things, both the undergraduate and the post-graduate public health (including clinical pharmacy) 44 training and skills of pharmacists, as well as the career structure of community pharmacists. In addition, it will be necessary to enable the development of a mixed market in community pharmacy practice by encouraging more pharmacists to be employed in GP practices, as well as for the government to contract public health services directly to individual or group pharmacists, who are not constrained by the burden of the dispensing role. Yet pharmacists should also be encouraged to use newer technologies, 44 including social media, to enhance their public health practice. 
